2m 2m 2m 2m 2m 2m 2m
MANNKIND (MNKD)
NASDAQ
$3.94+$0.03 (+0.77%)
Price as of Aug 03, 2026 6:21 AM EDT- $1.2BMarket Cap
- 4.27%1-Year Change
- BiotechnologyIndustry
MANNKIND (MNKD)
$3.94+$0.03 (+0.77%)
MNKD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.91 | ||
Change | -$0.20 (-4.87%) | ||
Open | $4.09 | ||
High | $4.14 | ||
Low | $3.85 | ||
Previous Close | $4.11 | ||
Volume | 5,404,120 | ||
30-Day Average Volume | 4,673,302 | ||
1-Week Change | -5.33% | ||
1-Month Change | -8.22% | ||
1-Year Change | 4.27% | ||
3-Year Change | -14.44% | ||
5-Year Change | -4.63% | ||
Fundamentals | |||
Shares Outstanding | 309.0M | ||
Total Assets | $744.4M | ||
Market Cap | $1.2B | ||
Enterprise Value | $1.5B | ||
Period: QTR TTM FY | |||
Revenue | $33.9M | ||
Net Income | -$16.6M | ||
Free Cash Flow | -$7.2M | ||
EBIT | -$3.9M | ||
EBITDA | $2.5M | ||
Net Working Capital | $116.6M | ||
EPS | -$0.05 | ||
Enterprise Value/EBITDA | 616 | ||
Enterprise Value/Revenue | 45 | ||
P/B | -20 | ||
P/E | -78 | ||
PEG | -40 | ||
Price/Free Cash Flow | -167 | ||
Price/Operating Cash Flow | -225 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 5 | ||
Last Split Date | 03/03/2017 | ||
Earnings & Revenue